 | • レポートコード：D0804-16404 • 出版社/出版日：GlobalInfoResearch / 2020年7月28日 ※2025年版があります。お問い合わせください。 • レポート形態：英語、PDF、129ページ • 納品方法：Eメール • 産業分類：医療 |
| Single User | ￥504,600 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥756,900 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,009,200 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートでは、プラスミドの世界市場を広く調査・分析し、今後の市場展望をまとめております。プラスミドの種類別市場規模（F-プラスミド、Colプラスミド、耐性プラスミド、不可解なプラスミド、分解性プラスミド、病原性プラスミド）、用途別市場規模（トランスフェクション、リコンビナントDNAテクノロジー、遺伝子治療、その他）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェアなどの情報を掲載しています。 ・市場概要 ・企業情報（販売量、市場シェア、製品概要、SWOT分析）：Aldevron、Cobra Biologics、VGXI Inc.、GenScript、Altogen Biosystems、PlasmidFactory GmbH & Co. KG、Takara Bio、Applied StemCell、Oxford Genetics Ltd.、Copernicus Therapeutics Inc.、Mirus Bio LLC、Polyplus Transfection、InvivoGen、MolMed S.p.A.、MaxCyte Inc.、Miltenyi Biotec、GenePharma、Medigene Sdn Bhd ・地域別グローバル市場分析 2015年-2020年 ・プラスミドの北米市場（アメリカ、カナダ、メキシコ） ・プラスミドのヨーロッパ市場（ドイツ、イギリス、フランス、ロシア、イタリア） ・プラスミドのアジア市場（中国、日本、韓国、インド、東南アジア、オーストラリア） ・プラスミドの南米市場（ブラジル、アルゼンチン） ・プラスミドの中東・アフリカ市場（サウジアラビア、トルコ、エジプト、南アフリカ） ・種類別分析：F-プラスミド、Colプラスミド、耐性プラスミド、不可解なプラスミド、分解性プラスミド、病原性プラスミド ・用途別分析：トランスフェクション、リコンビナントDNAテクノロジー、遺伝子治療、その他 ・地域別市場規模予測 2021年-2025年 ・調査の結果・結論 |
Market Overview
The Plasmid market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
The most likely (base case) scenario is that the global Plasmid sales will be xx in 2020 from Plasmid million in 2019, with a change xx% between 2019 and 2020. In addition, based on the latest study, it is to predict that the Covid-19 will be under control in key countries like the United States, Western Europe, East Asia, by the end of Q2 (June), and will resume normal production in Q3 and Q4, the global Plasmid market size is expected to grow at xx% or more annually for the next five years.
This report also researches and evaluates the impact of Covid-19 outbreak on the Plasmid industry, involving potential opportunity and challenges, drivers and risks. We present the impact assessment of Covid-19 effects on Plasmid and market growth forecast based on different scenario (optimistic, pessimistic, very optimistic, most likely etc.).
Market segmentation
Plasmid market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Plasmid market has been segmented into:
F-Plasmids
Col Plasmids
Resistance Plasmids
Cryptic Plasmids
Degradative Plasmids
Virulence Plasmids
By Application, Plasmid has been segmented into:
Transfection
Recombinant DNA Technology
Gene Therapy
Others
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Plasmid market presented in the report. This section sheds light on the sales growth of different regional and country-level Plasmid markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Plasmid market.
The report offers in-depth assessment of the growth and other aspects of the Plasmid market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Australia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Competitive Landscape and Plasmid Market Share Analysis
Plasmid competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Plasmid sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Plasmid sales, revenue and market share for each player covered in this report.
The major players covered in Plasmid are:
Aldevron
Cobra Biologics
VGXI Inc.
GenScript
Altogen Biosystems
PlasmidFactory GmbH & Co. KG
Takara Bio
Applied StemCell
Oxford Genetics Ltd.
Copernicus Therapeutics Inc.
Mirus Bio LLC
Polyplus Transfection
InvivoGen
MolMed S.p.A.
MaxCyte Inc.
Miltenyi Biotec
GenePharma
Medigene Sdn Bhd
1 Plasmid Market Overview
1.1 Product Overview and Scope of Plasmid
1.2 Classification of Plasmid by Type
1.2.1 Global Plasmid Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Global Plasmid Revenue Market Share by Type in 2019
1.2.3 F-Plasmids
1.2.4 Col Plasmids
1.2.5 Resistance Plasmids
1.2.6 Cryptic Plasmids
1.2.7 Degradative Plasmids
1.2.8 Virulence Plasmids
1.3 Global Plasmid Market by Application
1.3.1 Overview: Global Plasmid Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Transfection
1.3.3 Recombinant DNA Technology
1.3.4 Gene Therapy
1.3.5 Others
1.4 Global Plasmid Market by Regions
1.4.1 Global Plasmid Market Size by Regions: 2015 VS 2019 VS 2025
1.4.2 Global Market Size of Plasmid (2015-2025)
1.4.3 North America (USA, Canada and Mexico) Plasmid Status and Prospect (2015-2025)
1.4.4 Europe (Germany, France, UK, Russia and Italy) Plasmid Status and Prospect (2015-2025)
1.4.5 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Plasmid Status and Prospect (2015-2025)
1.4.6 South America (Brazil, Argentina, Colombia) Plasmid Status and Prospect (2015-2025)
1.4.7 Middle East & Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Plasmid Status and Prospect (2015-2025)
1.5 COVID-19 Outbreak: Plasmid Industry Impact
1.5.1 COVID-19 Potential Implications for the Plasmid
1.5.1.1 Scenario One: Very Optimistic: COVID-19 has No Influence on Plasmid
1.5.1.2 Scenario Two: Optimistic: COVID-19 Will Be Under Control by the End of April
1.5.1.3 Scenario Three: Gloomy: COVID-19 Will Be Under Control Between Q3 and Q4
1.5.1.4 Scenario Four: Most Likely: COVID-19 Will Be Under Control by the End of Q2
1.5.2 Opportunity Analysis in Covid-19 Crisis
1.5.3 Market Risk and Restraints
1.5.4 Market Driving Force
2 Company Profiles
2.1 Aldevron
2.1.1 Aldevron Details
2.1.2 Aldevron Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Aldevron SWOT Analysis
2.1.4 Aldevron Product and Services
2.1.5 Aldevron Plasmid Revenue, Gross Margin and Market Share (2018-2019)
2.2 Cobra Biologics
2.2.1 Cobra Biologics Details
2.2.2 Cobra Biologics Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Cobra Biologics SWOT Analysis
2.2.4 Cobra Biologics Product and Services
2.2.5 Cobra Biologics Plasmid Revenue, Gross Margin and Market Share (2018-2019)
2.3 VGXI Inc.
2.3.1 VGXI Inc. Details
2.3.2 VGXI Inc. Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 VGXI Inc. SWOT Analysis
2.3.4 VGXI Inc. Product and Services
2.3.5 VGXI Inc. Plasmid Revenue, Gross Margin and Market Share (2018-2019)
2.4 GenScript
2.4.1 GenScript Details
2.4.2 GenScript Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 GenScript SWOT Analysis
2.4.4 GenScript Product and Services
2.4.5 GenScript Plasmid Revenue, Gross Margin and Market Share (2018-2019)
2.5 Altogen Biosystems
2.5.1 Altogen Biosystems Details
2.5.2 Altogen Biosystems Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 Altogen Biosystems SWOT Analysis
2.5.4 Altogen Biosystems Product and Services
2.5.5 Altogen Biosystems Plasmid Revenue, Gross Margin and Market Share (2018-2019)
2.6 PlasmidFactory GmbH & Co. KG
2.6.1 PlasmidFactory GmbH & Co. KG Details
2.6.2 PlasmidFactory GmbH & Co. KG Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 PlasmidFactory GmbH & Co. KG SWOT Analysis
2.6.4 PlasmidFactory GmbH & Co. KG Product and Services
2.6.5 PlasmidFactory GmbH & Co. KG Plasmid Revenue, Gross Margin and Market Share (2018-2019)
2.7 Takara Bio
2.7.1 Takara Bio Details
2.7.2 Takara Bio Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 Takara Bio SWOT Analysis
2.7.4 Takara Bio Product and Services
2.7.5 Takara Bio Plasmid Revenue, Gross Margin and Market Share (2018-2019)
2.8 Applied StemCell
2.8.1 Applied StemCell Details
2.8.2 Applied StemCell Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 Applied StemCell SWOT Analysis
2.8.4 Applied StemCell Product and Services
2.8.5 Applied StemCell Plasmid Revenue, Gross Margin and Market Share (2018-2019)
2.9 Oxford Genetics Ltd.
2.9.1 Oxford Genetics Ltd. Details
2.9.2 Oxford Genetics Ltd. Major Business and Total Revenue (Financial Highlights) Analysis
2.9.3 Oxford Genetics Ltd. SWOT Analysis
2.9.4 Oxford Genetics Ltd. Product and Services
2.9.5 Oxford Genetics Ltd. Plasmid Revenue, Gross Margin and Market Share (2018-2019)
2.10 Copernicus Therapeutics Inc.
2.10.1 Copernicus Therapeutics Inc. Details
2.10.2 Copernicus Therapeutics Inc. Major Business and Total Revenue (Financial Highlights) Analysis
2.10.3 Copernicus Therapeutics Inc. SWOT Analysis
2.10.4 Copernicus Therapeutics Inc. Product and Services
2.10.5 Copernicus Therapeutics Inc. Plasmid Revenue, Gross Margin and Market Share (2018-2019)
2.11 Mirus Bio LLC
2.11.1 Mirus Bio LLC Details
2.11.2 Mirus Bio LLC Major Business and Total Revenue (Financial Highlights) Analysis
2.11.3 Mirus Bio LLC SWOT Analysis
2.11.4 Mirus Bio LLC Product and Services
2.11.5 Mirus Bio LLC Plasmid Revenue, Gross Margin and Market Share (2018-2019)
2.12 Polyplus Transfection
2.12.1 Polyplus Transfection Details
2.12.2 Polyplus Transfection Major Business and Total Revenue (Financial Highlights) Analysis
2.12.3 Polyplus Transfection SWOT Analysis
2.12.4 Polyplus Transfection Product and Services
2.12.5 Polyplus Transfection Plasmid Revenue, Gross Margin and Market Share (2018-2019)
2.13 InvivoGen
2.13.1 InvivoGen Details
2.13.2 InvivoGen Major Business and Total Revenue (Financial Highlights) Analysis
2.13.3 InvivoGen SWOT Analysis
2.13.4 InvivoGen Product and Services
2.13.5 InvivoGen Plasmid Revenue, Gross Margin and Market Share (2018-2019)
2.14 MolMed S.p.A.
2.14.1 MolMed S.p.A. Details
2.14.2 MolMed S.p.A. Major Business and Total Revenue (Financial Highlights) Analysis
2.14.3 MolMed S.p.A. SWOT Analysis
2.14.4 MolMed S.p.A. Product and Services
2.14.5 MolMed S.p.A. Plasmid Revenue, Gross Margin and Market Share (2018-2019)
2.15 MaxCyte Inc.
2.15.1 MaxCyte Inc. Details
2.15.2 MaxCyte Inc. Major Business and Total Revenue (Financial Highlights) Analysis
2.15.3 MaxCyte Inc. SWOT Analysis
2.15.4 MaxCyte Inc. Product and Services
2.15.5 MaxCyte Inc. Plasmid Revenue, Gross Margin and Market Share (2018-2019)
2.16 Miltenyi Biotec
2.16.1 Miltenyi Biotec Details
2.16.2 Miltenyi Biotec Major Business and Total Revenue (Financial Highlights) Analysis
2.16.3 Miltenyi Biotec SWOT Analysis
2.16.4 Miltenyi Biotec Product and Services
2.16.5 Miltenyi Biotec Plasmid Revenue, Gross Margin and Market Share (2018-2019)
2.17 GenePharma
2.17.1 GenePharma Details
2.17.2 GenePharma Major Business and Total Revenue (Financial Highlights) Analysis
2.17.3 GenePharma SWOT Analysis
2.17.4 GenePharma Product and Services
2.17.5 GenePharma Plasmid Revenue, Gross Margin and Market Share (2018-2019)
2.18 Medigene Sdn Bhd
2.18.1 Medigene Sdn Bhd Details
2.18.2 Medigene Sdn Bhd Major Business and Total Revenue (Financial Highlights) Analysis
2.18.3 Medigene Sdn Bhd SWOT Analysis
2.18.4 Medigene Sdn Bhd Product and Services
2.18.3 Medigene Sdn Bhd Plasmid Revenue, Gross Margin and Market Share (2018-2019)
3 Market Competition, by Players
3.1 Global Plasmid Revenue and Share by Players (2015-2020)
3.2 Market Concentration Rate
3.2.1 Top 5 Plasmid Players Market Share
3.2.2 Top 10 Plasmid Players Market Share
3.3 Market Competition Trend
4 Market Size by Regions
4.1 Global Plasmid Revenue and Market Share by Regions
4.2 North America Plasmid Revenue and Growth Rate (2015-2020)
4.3 Europe Plasmid Revenue and Growth Rate (2015-2020)
4.4 Asia-Pacific Plasmid Revenue and Growth Rate (2015-2020)
4.5 South America Plasmid Revenue and Growth Rate (2015-2020)
4.6 Middle East & Africa Plasmid Revenue and Growth Rate (2015-2020)
5 North America Plasmid Revenue by Countries
5.1 North America Plasmid Revenue by Countries (2015-2020)
5.2 USA Plasmid Revenue and Growth Rate (2015-2020)
5.3 Canada Plasmid Revenue and Growth Rate (2015-2020)
5.4 Mexico Plasmid Revenue and Growth Rate (2015-2020)
6 Europe Plasmid Revenue by Countries
6.1 Europe Plasmid Revenue by Countries (2015-2020)
6.2 Germany Plasmid Revenue and Growth Rate (2015-2020)
6.3 UK Plasmid Revenue and Growth Rate (2015-2020)
6.4 France Plasmid Revenue and Growth Rate (2015-2020)
6.5 Russia Plasmid Revenue and Growth Rate (2015-2020)
6.6 Italy Plasmid Revenue and Growth Rate (2015-2020)
7 Asia-Pacific Plasmid Revenue by Countries
7.1 Asia-Pacific Plasmid Revenue by Countries (2015-2020)
7.2 China Plasmid Revenue and Growth Rate (2015-2020)
7.3 Japan Plasmid Revenue and Growth Rate (2015-2020)
7.4 Korea Plasmid Revenue and Growth Rate (2015-2020)
7.5 India Plasmid Revenue and Growth Rate (2015-2020)
7.6 Southeast Asia Plasmid Revenue and Growth Rate (2015-2020)
8 South America Plasmid Revenue by Countries
8.1 South America Plasmid Revenue by Countries (2015-2020)
8.2 Brazil Plasmid Revenue and Growth Rate (2015-2020)
8.3 Argentina Plasmid Revenue and Growth Rate (2015-2020)
9 Middle East & Africa Revenue Plasmid by Countries
9.1 Middle East & Africa Plasmid Revenue by Countries (2015-2020)
9.2 Saudi Arabia Plasmid Revenue and Growth Rate (2015-2020)
9.3 UAE Plasmid Revenue and Growth Rate (2015-2020)
9.4 Egypt Plasmid Revenue and Growth Rate (2015-2020)
9.5 South Africa Plasmid Revenue and Growth Rate (2015-2020)
10 Market Size Segment by Type
10.1 Global Plasmid Revenue and Market Share by Type (2015-2020)
10.2 Global Plasmid Market Forecast by Type (2019-2024)
10.3 F-Plasmids Revenue Growth Rate (2015-2025)
10.4 Col Plasmids Revenue Growth Rate (2015-2025)
10.5 Resistance Plasmids Revenue Growth Rate (2015-2025)
10.6 Cryptic Plasmids Revenue Growth Rate (2015-2025)
10.7 Degradative Plasmids Revenue Growth Rate (2015-2025)
10.8 Virulence Plasmids Revenue Growth Rate (2015-2025)
11 Global Plasmid Market Segment by Application
11.1 Global Plasmid Revenue Market Share by Application (2015-2020)
11.2 Plasmid Market Forecast by Application (2019-2024)
11.3 Transfection Revenue Growth (2015-2020)
11.4 Recombinant DNA Technology Revenue Growth (2015-2020)
11.5 Gene Therapy Revenue Growth (2015-2020)
11.6 Others Revenue Growth (2015-2020)
12 Global Plasmid Market Size Forecast (2021-2025)
12.1 Global Plasmid Market Size Forecast (2021-2025)
12.2 Global Plasmid Market Forecast by Regions (2021-2025)
12.3 North America Plasmid Revenue Market Forecast (2021-2025)
12.4 Europe Plasmid Revenue Market Forecast (2021-2025)
12.5 Asia-Pacific Plasmid Revenue Market Forecast (2021-2025)
12.6 South America Plasmid Revenue Market Forecast (2021-2025)
12.7 Middle East & Africa Plasmid Revenue Market Forecast (2021-2025)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
14.3 Disclaimer
14.4 About US
Table 1. Global Plasmid Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Plasmid by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Plasmid Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Global Market Plasmid Revenue (Million USD) Comparison by Regions 2015-2025
Table 5. Global Plasmid Market Size and Growth Estimation in Various Scenarios in 2020
Table 6. Aldevron Corporate Information, Location and Competitors
Table 7. Aldevron Plasmid Major Business
Table 8. Aldevron Plasmid Total Revenue (USD Million) (2017-2018)
Table 9. Aldevron SWOT Analysis
Table 10. Aldevron Plasmid Product and Solutions
Table 11. Aldevron Plasmid Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 12. Cobra Biologics Corporate Information, Location and Competitors
Table 13. Cobra Biologics Plasmid Major Business
Table 14. Cobra Biologics Plasmid Total Revenue (USD Million) (2018-2019)
Table 15. Cobra Biologics SWOT Analysis
Table 16. Cobra Biologics Plasmid Product and Solutions
Table 17. Cobra Biologics Plasmid Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 18. VGXI Inc. Corporate Information, Location and Competitors
Table 19. VGXI Inc. Plasmid Major Business
Table 20. VGXI Inc. Plasmid Total Revenue (USD Million) (2017-2018)
Table 21. VGXI Inc. SWOT Analysis
Table 22. VGXI Inc. Plasmid Product and Solutions
Table 23. VGXI Inc. Plasmid Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 24. GenScript Corporate Information, Location and Competitors
Table 25. GenScript Plasmid Major Business
Table 26. GenScript Plasmid Total Revenue (USD Million) (2017-2018)
Table 27. GenScript SWOT Analysis
Table 28. GenScript Plasmid Product and Solutions
Table 29. GenScript Plasmid Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 30. Altogen Biosystems Corporate Information, Location and Competitors
Table 31. Altogen Biosystems Plasmid Major Business
Table 32. Altogen Biosystems Plasmid Total Revenue (USD Million) (2017-2018)
Table 33. Altogen Biosystems SWOT Analysis
Table 34. Altogen Biosystems Plasmid Product and Solutions
Table 35. Altogen Biosystems Plasmid Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 36. PlasmidFactory GmbH & Co. KG Corporate Information, Location and Competitors
Table 37. PlasmidFactory GmbH & Co. KG Plasmid Major Business
Table 38. PlasmidFactory GmbH & Co. KG Plasmid Total Revenue (USD Million) (2017-2018)
Table 39. PlasmidFactory GmbH & Co. KG SWOT Analysis
Table 40. PlasmidFactory GmbH & Co. KG Plasmid Product and Solutions
Table 41. PlasmidFactory GmbH & Co. KG Plasmid Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 42. Takara Bio Corporate Information, Location and Competitors
Table 43. Takara Bio Plasmid Major Business
Table 44. Takara Bio Plasmid Total Revenue (USD Million) (2017-2018)
Table 45. Takara Bio SWOT Analysis
Table 46. Takara Bio Plasmid Product and Solutions
Table 47. Takara Bio Plasmid Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 48. Applied StemCell Corporate Information, Location and Competitors
Table 49. Applied StemCell Plasmid Major Business
Table 50. Applied StemCell Plasmid Total Revenue (USD Million) (2017-2018)
Table 51. Applied StemCell SWOT Analysis
Table 52. Applied StemCell Plasmid Product and Solutions
Table 53. Applied StemCell Plasmid Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 54. Oxford Genetics Ltd. Corporate Information, Location and Competitors
Table 55. Oxford Genetics Ltd. Plasmid Major Business
Table 56. Oxford Genetics Ltd. Plasmid Total Revenue (USD Million) (2017-2018)
Table 57. Oxford Genetics Ltd. SWOT Analysis
Table 58. Oxford Genetics Ltd. Plasmid Product and Solutions
Table 59. Oxford Genetics Ltd. Plasmid Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 60. Copernicus Therapeutics Inc. Corporate Information, Location and Competitors
Table 61. Copernicus Therapeutics Inc. Plasmid Major Business
Table 62. Copernicus Therapeutics Inc. Plasmid Total Revenue (USD Million) (2017-2018)
Table 63. Copernicus Therapeutics Inc. SWOT Analysis
Table 64. Copernicus Therapeutics Inc. Plasmid Product and Solutions
Table 65. Copernicus Therapeutics Inc. Plasmid Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 66. Mirus Bio LLC Corporate Information, Location and Competitors
Table 67. Mirus Bio LLC Plasmid Major Business
Table 68. Mirus Bio LLC Plasmid Total Revenue (USD Million) (2017-2018)
Table 69. Mirus Bio LLC SWOT Analysis
Table 70. Mirus Bio LLC Plasmid Product and Solutions
Table 71. Mirus Bio LLC Plasmid Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 72. Polyplus Transfection Corporate Information, Location and Competitors
Table 73. Polyplus Transfection Plasmid Major Business
Table 74. Polyplus Transfection Plasmid Total Revenue (USD Million) (2017-2018)
Table 75. Polyplus Transfection SWOT Analysis
Table 76. Polyplus Transfection Plasmid Product and Solutions
Table 77. Polyplus Transfection Plasmid Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 78. InvivoGen Corporate Information, Location and Competitors
Table 79. InvivoGen Plasmid Major Business
Table 80. InvivoGen Plasmid Total Revenue (USD Million) (2017-2018)
Table 81. InvivoGen SWOT Analysis
Table 82. InvivoGen Plasmid Product and Solutions
Table 83. InvivoGen Plasmid Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 84. MolMed S.p.A. Corporate Information, Location and Competitors
Table 85. MolMed S.p.A. Plasmid Major Business
Table 86. MolMed S.p.A. Plasmid Total Revenue (USD Million) (2017-2018)
Table 87. MolMed S.p.A. SWOT Analysis
Table 88. MolMed S.p.A. Plasmid Product and Solutions
Table 89. MolMed S.p.A. Plasmid Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 90. MaxCyte Inc. Corporate Information, Location and Competitors
Table 91. MaxCyte Inc. Plasmid Major Business
Table 92. MaxCyte Inc. Plasmid Total Revenue (USD Million) (2017-2018)
Table 93. MaxCyte Inc. SWOT Analysis
Table 94. MaxCyte Inc. Plasmid Product and Solutions
Table 95. MaxCyte Inc. Plasmid Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 96. Miltenyi Biotec Corporate Information, Location and Competitors
Table 97. Miltenyi Biotec Plasmid Major Business
Table 98. Miltenyi Biotec Plasmid Total Revenue (USD Million) (2017-2018)
Table 99. Miltenyi Biotec SWOT Analysis
Table 100. Miltenyi Biotec Plasmid Product and Solutions
Table 101. Miltenyi Biotec Plasmid Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 102. GenePharma Corporate Information, Location and Competitors
Table 103. GenePharma Plasmid Major Business
Table 104. GenePharma Plasmid Total Revenue (USD Million) (2017-2018)
Table 105. GenePharma SWOT Analysis
Table 106. GenePharma Plasmid Product and Solutions
Table 107. GenePharma Plasmid Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 108. Medigene Sdn Bhd Plasmid Type and Application
Table 109. Medigene Sdn Bhd Plasmid Major Business
Table 110. Medigene Sdn Bhd Plasmid Total Revenue (USD Million) (2017-2018)
Table 111. Medigene Sdn Bhd SWOT Analysis
Table 112. Medigene Sdn Bhd Plasmid Product and Solutions
Table 113. Medigene Sdn Bhd Plasmid Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 114. Global Plasmid Revenue (Million USD) by Players (2015-2020)
Table 115. Global Plasmid Revenue Share by Players (2015-2020)
Table 116. Global Plasmid Revenue (Million USD) by Regions (2015-2020)
Table 117. Global Plasmid Revenue Market Share by Regions (2015-2020)
Table 118. North America Plasmid Revenue by Countries (2015-2020)
Table 119. North America Plasmid Revenue Market Share by Countries (2015-2020)
Table 120. Europe Plasmid Revenue (Million USD) by Countries (2015-2020)
Table 121. Asia-Pacific Plasmid Revenue (Million USD) by Countries (2015-2020)
Table 122. South America Plasmid Revenue by Countries (2015-2020)
Table 123. South America Plasmid Revenue Market Share by Countries (2015-2020)
Table 124. Middle East and Africa Plasmid Revenue (Million USD) by Countries (2015-2020)
Table 125. Middle East and Africa Plasmid Revenue Market Share by Countries (2015-2020)
Table 126. Global Plasmid Revenue (Million USD) by Type (2015-2020)
Table 127. Global Plasmid Revenue Share by Type (2015-2020)
Table 128. Global Plasmid Revenue Forecast by Type (2021-2025)
Table 129. Global Plasmid Revenue by Application (2015-2020)
Table 130. Global Plasmid Revenue Share by Application (2015-2020)
Table 131. Global Plasmid Revenue Forecast by Application (2021-2025)
Table 132. Global Plasmid Revenue (Million USD) Forecast by Regions (2021-2025)
List of Figures
Figure 1. Plasmid Picture
Figure 2. Global Plasmid Revenue Market Share by Type in 2019
Figure 3. F-Plasmids Picture
Figure 4. Col Plasmids Picture
Figure 5. Resistance Plasmids Picture
Figure 6. Cryptic Plasmids Picture
Figure 7. Degradative Plasmids Picture
Figure 8. Virulence Plasmids Picture
Figure 9. Plasmid Revenue Market Share by Application in 2019
Figure 10. Transfection Picture
Figure 11. Recombinant DNA Technology Picture
Figure 12. Gene Therapy Picture
Figure 13. Others Picture
Figure 14. Global Plasmid Revenue (USD Million) and Growth Rate (2015-2025)
Figure 15. North America Plasmid Revenue (Million USD) and Growth Rate (2015-2025)
Figure 16. Europe Plasmid Revenue (Million USD) and Growth Rate (2015-2025)
Figure 17. Asia-Pacific Plasmid Revenue (Million USD) and Growth Rate (2015-2025)
Figure 18. South America Plasmid Revenue (Million USD) and Growth Rate (2015-2025)
Figure 19. Middle East and Africa Plasmid Revenue (Million USD) and Growth Rate (2015-2025)
Figure 20. Global Plasmid Revenue (Million USD) and Growth Rate (2015-2025)
Figure 21. Global Plasmid Revenue Share by Players in 2019
Figure 22. Global Top 5 Players Plasmid Revenue Market Share in 2019
Figure 23. Global Top 10 Players Plasmid Revenue Market Share in 2019
Figure 24. Key Players Market Share Trend
Figure 25. Global Plasmid Revenue (Million USD) and Growth Rate (%) (2015-2020)
Figure 26. Global Plasmid Revenue Market Share by Regions (2015-2020)
Figure 27. Global Plasmid Revenue Market Share by Regions in 2018
Figure 28. North America Plasmid Revenue and Growth Rate (2015-2020)
Figure 29. Europe Plasmid Revenue and Growth Rate (2015-2020)
Figure 30. Asia-Pacific Plasmid Revenue and Growth Rate (2015-2020)
Figure 31. South America Plasmid Revenue and Growth Rate (2015-2020)
Figure 32. Middle East and Africa Plasmid Revenue and Growth Rate (2015-2020)
Figure 33. North America Plasmid Revenue Market Share by Countries (2015-2020)
Figure 34. North America Plasmid Revenue Market Share by Countries in 2019
Figure 35. USA Plasmid Revenue and Growth Rate (2015-2020)
Figure 36. Canada Plasmid Revenue and Growth Rate (2015-2020)
Figure 37. Mexico Plasmid Revenue and Growth Rate (2015-2020)
Figure 38. Europe Plasmid Revenue Market Share by Countries (2015-2020)
Figure 39. Europe Plasmid Revenue Market Share by Countries in 2019
Figure 40. Germany Plasmid Revenue and Growth Rate (2015-2020)
Figure 41. UK Plasmid Revenue and Growth Rate (2015-2020)
Figure 42. France Plasmid Revenue and Growth Rate (2015-2020)
Figure 43. Russia Plasmid Revenue and Growth Rate (2015-2020)
Figure 44. Italy Plasmid Revenue and Growth Rate (2015-2020)
Figure 45. Asia-Pacific Plasmid Revenue Market Share by Countries (2015-2020)
Figure 46. Asia-Pacific Plasmid Revenue Market Share by Countries in 2019
Figure 47. China Plasmid Revenue and Growth Rate (2015-2020)
Figure 48. Japan Plasmid Revenue and Growth Rate (2015-2020)
Figure 49. Korea Plasmid Revenue and Growth Rate (2015-2020)
Figure 50. India Plasmid Revenue and Growth Rate (2015-2020)
Figure 51. Southeast Asia Plasmid Revenue and Growth Rate (2015-2020)
Figure 52. South America Plasmid Revenue Market Share by Countries (2015-2020)
Figure 53. South America Plasmid Revenue Market Share by Countries in 2019
Figure 54. Brazil Plasmid Revenue and Growth Rate (2015-2020)
Figure 55. Argentina Plasmid Revenue and Growth Rate (2015-2020)
Figure 56. Middle East and Africa Plasmid Revenue Market Share by Countries (2015-2020)
Figure 57. Middle East and Africa Plasmid Revenue Market Share by Countries in 2019
Figure 58. Saudi Arabia Plasmid Revenue and Growth Rate (2015-2020)
Figure 59. UAE Plasmid Revenue and Growth Rate (2015-2020)
Figure 60. Egypt Plasmid Revenue and Growth Rate (2015-2020)
Figure 61. South Africa Plasmid Revenue and Growth Rate (2015-2020)
Figure 62. Global Plasmid Revenue Share by Type (2015-2020)
Figure 63. Global Plasmid Revenue Share by Type in 2019
Figure 64. Global Plasmid Market Share Forecast by Type (2021-2025)
Figure 65. Global F-Plasmids Revenue Growth Rate (2015-2020)
Figure 66. Global Col Plasmids Revenue Growth Rate (2015-2020)
Figure 67. Global Resistance Plasmids Revenue Growth Rate (2015-2020)
Figure 68. Global Cryptic Plasmids Revenue Growth Rate (2015-2020)
Figure 69. Global Degradative Plasmids Revenue Growth Rate (2015-2020)
Figure 70. Global Virulence Plasmids Revenue Growth Rate (2015-2020)
Figure 71. Global Plasmid Revenue Share by Application (2015-2020)
Figure 72. Global Plasmid Revenue Share by Application in 2019
Figure 73. Global Plasmid Market Share Forecast by Application (2021-2025)
Figure 74. Global Transfection Revenue Growth Rate (2015-2020)
Figure 75. Global Recombinant DNA Technology Revenue Growth Rate (2015-2020)
Figure 76. Global Gene Therapy Revenue Growth Rate (2015-2020)
Figure 77. Global Others Revenue Growth Rate (2015-2020)
Figure 78. Global Plasmid Revenue (Million USD) and Growth Rate Forecast (2021-2025)
Figure 79. Global Plasmid Revenue (Million USD) Forecast by Regions (2021-2025)
Figure 80. Global Plasmid Revenue Market Share Forecast by Regions (2021-2025)
Figure 81. North America Plasmid Revenue Market Forecast (2021-2025)
Figure 82. Europe Plasmid Revenue Market Forecast (2021-2025)
Figure 83. Asia-Pacific Plasmid Revenue Market Forecast (2021-2025)
Figure 84. South America Plasmid Revenue Market Forecast (2021-2025)
Figure 85. Middle East and Africa Plasmid Revenue Market Forecast (2021-2025)
Figure 86. Sales Channel: Direct Channel vs Indirect Channel
ウイルスベクター・プラスミドDNA製造の世界市場 2020年：企業別・地域別・種類別・用途別市場予測 Market Overview The Viral Vectors and Plasmid DNA Manufacturing market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, val…- ウイルスベクター・プラスミドDNAの世界市場 2020年：企業別、地域別、種類・用途別 Market Overview The Viral Vector and Plasmid DNA market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimi…
- 抗生物質耐性バイオマーカーの世界市場 2020年：企業別、地域別、種類・用途別 Market Overview The global Antibiotic Resistance Biomarkers market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Antibiotic R…
- 船舶用耐食コーティング剤の世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The Corrosion Resistance Coatings for Marine market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value …
- 抵抗合金の世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global Resistance Alloys market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Resistance Alloys market re…